⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17866814 | 0.80 | — | — | |
| SCHEMBL8043358 | 0.80 | — | — | |
| SCHEMBL30685409 | 0.75 | — | — | |
| SCHEMBL28554993 | 0.75 | — | — | |
| SCHEMBL16431290 | 0.75 | — | — | |
| SCHEMBL7152305 | 0.71 | — | — | |
| SCHEMBL4041071 | 0.67 | — | — | |
| SCHEMBL10704952 | 0.65 | MAPK1 (0.35) | — | |
| SCHEMBL1132681 | 0.64 | — | — | |
| SCHEMBL8975729 | 0.63 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 42 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260053912-A1 | STEROLS AS NOVEL IMMUNOMODULATORY AGENTS AND THEIR USE AS VACCINE ADJUVANTS | UNITED STATES GOVERNMENT | 2026-02-26 | — | — | US | disclosed |
| EP-4700124-A2 | OLIGONUCLEOTIDE-LIGAND CONJUGATES AND PROCESS FOR THEIR PREPARATION | Alnylam Pharmaceuticals, Inc. (US) | 2026-02-25 | — | — | EP | disclosed |
| US-20260021189-A1 | PHARMACEUTICAL COMPOSITION AND METHOD OF TREATING HEPATITIS | SeeCure Taiwan Co., Ltd. (TW) | 2026-01-22 | — | — | US | disclosed |
| US-12508320-B2 | Drug conjugate, pharmaceutical composition and method of treating hepatitis | SeeCure Taiwan Co., Ltd. (TW) | 2025-12-30 | — | — | US | disclosed |
| US-12478671-B2 | Sterols as novel immunomodulatory agents and their use as vaccine adjuvants | OHIO STATE INNOVATION FOUNDATION (US) | 2025-11-25 | — | — | US | disclosed |
| US-20250338808-A1 | COMPOSITIONS AND METHODS FOR MODULATING IMMUNITY IN PLANTS | BOYCE THOMPSON INSTITUTE FOR PLANT RES INC (US) | 2025-11-06 | — | — | US | disclosed |
| US-12382888-B2 | Compositions and methods for modulating immunity in plants | BOYCE THOMPSON INSTITUTE FOR PLANT RESEARCH, INC. (US) | 2025-08-12 | — | — | US | disclosed |
| US-20250236685-A1 | DEGRADABLE POLYMERS | THE TRUSTEES OF BOSTON COLLEGE | 2025-07-24 | — | — | US | disclosed |
| US-20250228953-A1 | INTRACELLULAR TARGETING OF OLIGONUCLEOTIDES | ENTRADA THERAPEUTICS, INC. | 2025-07-17 | — | — | US | disclosed |
| US-20250179108-A1 | UTILITY OF NEMATODE SMALL MOLECULES | BOYCE THOMPSON INSTITUTE FOR PLANT RESEARCH | 2025-06-05 | — | — | US | disclosed |
| US-20220409650-A1 | COMPOSITIONS AND METHODS FOR ASCAROSIDE MODIFICATION OF MAMMALIAN MICROBIOTA | HOLOCLARA INC (US) | 2022-12-29 | — | — | US | disclosed |
| WO-2022246195-A1 | FUNCTIONAL MOIETIES AND THEIR USES AND SYNTHETIC PREPARATION | OLIX US, INC. (US) | 2022-11-24 | — | — | WO | disclosed |
| US-20220348914-A1 | OLIGONUCLEOTIDE-LIGAND CONJUGATES AND PROCESS FOR THEIR PREPARATION | BANK OF AMERICA, N.A. | 2022-11-03 | — | — | US | disclosed |
| EP-4074344-A1 | TARGETING LIPIDS | Arbutus Biopharma Corporation (CA) | 2022-10-19 | — | — | EP | disclosed |
| US-11471479-B2 | Polysaccharide and nucleic acid formulations containing viscosity-lowering agents | EAGLE BIOLOGICS, INC. (US) | 2022-10-18 | — | — | US | disclosed |
| EP-4039278-A1 | OLIGONUCLEOTIDE-LIGAND CONJUGATES AND PROCESS FOR THEIR PREPARATION | Alnylam Pharmaceuticals, Inc. (US) | 2022-08-10 | — | — | EP | disclosed |
| EP-4025252-A1 | ASIALOGLYCOPROTEIN RECEPTOR MEDIATED DELIVERY OF THERAPEUTICALLY ACTIVE CONJUGATES | Arcturus Therapeutics, Inc. (US) | 2022-07-13 | — | — | EP | disclosed |
| US-20220143189-A1 | CARBOHYDRATE CONJUGATES AS DELIVERY AGENTS FOR OLIGONUCLEOTIDES | BANK OF AMERICA, N.A. | 2022-05-12 | — | — | US | disclosed |
| US-20220127605-A1 | NUCLEIC ACID CONJUGATE | KYOWA KIRIN CO., LTD. (JP) | 2022-04-28 | — | — | US | disclosed |
| EP-3019200-B1 | OLIGONUCLEOTIDE-LIGAND CONJUGATES AND PROCESS FOR THEIR PREPARATION | ALNYLAM PHARMACEUTICALS INC (US) | 2022-03-23 | — | — | EP | disclosed |